TheraME! peer-reviewed, high impact
Publications

Patient-specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies. Eduati F, Jaaks P, Wappler J, Cramer T, Merten CA, Garnett MJ, Saez-Rodriguez J. Molecular Systems Biology (16)e8664: 1-13, 2020
Microfluidics as an Enabling Technology for Personalized Cancer Therapy. Mathur L*, Ballinger M*, Utharala R*, Merten CA. Small. E1904321: 1-18, 2019
A microfluidics platform for combinatorial drug screening on cancer biopsies. Eduati F*, Utharala R*, Madhavan D, Neumann UP, Longerich T, Cramer T, Saez-Rodriguez J, Merten CA. Nature Communications. 9(1):2434: 1-13, 2018